DEFA14A: Aimei Health Technology Adjourns Extraordinary General Meeting to February 5, 2025
Proxy Statement Supplement
Aimei Health Technology Co., Ltd. announced the adjournment of its Extraordinary General Meeting to February 5, 2025.
Summary
- Aimei Health Technology Co., Ltd. filed a definitive proxy statement with the SEC on January 21, 2025, regarding its Extraordinary General Meeting of shareholders.
- Additional proxy materials were filed on January 30, 2025, to supplement the initial proxy statement.
- On February 4, 2025, the company announced via Form 8-K that the Extraordinary General Meeting would be adjourned until February 5, 2025.
- This supplement is intended to broadly disseminate the information about the adjournment.
Sentiment
Score: 5
Explanation: The document is a neutral announcement regarding the adjournment of a meeting; it doesn't convey strong positive or negative sentiment.
Stakeholder Impact
- Shareholders need to be aware of the change in date for the Extraordinary General Meeting.
Key Dates
| Date | Description |
|---|---|
| January 21, 2025 | Filing of definitive proxy statement with the SEC |
| January 30, 2025 | Filing of additional proxy materials |
| February 4, 2025 | Announcement of adjournment of Extraordinary General Meeting via Form 8-K |
| February 5, 2025 | Rescheduled date for the Extraordinary General Meeting |
Keywords
Extraordinary General Meeting, Proxy Statement, Adjournment, Aimei Health Technology, Shareholders, SEC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.